New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine
New York Hospitals Conducting COVID-19 Drug Trial Using Common Heartburn Medicine

Researchers are looking into whether high doses of famotidine could be used to treat COVID-19 patients.

Business Insider reports that Famotidine is the active ingredient in the heartburn medication Pepcid.

A clinical trial is currently underway, with researchers aiming to recruit 1,200 patients.

The trial is investigating if high doses of famotidine help critically ill coronavirus patients survive.